BUSSINI, LINDA
 Distribuzione geografica
Continente #
NA - Nord America 1.076
AS - Asia 896
EU - Europa 249
SA - Sud America 184
AF - Africa 22
OC - Oceania 1
Totale 2.428
Nazione #
US - Stati Uniti d'America 1.044
SG - Singapore 462
CN - Cina 164
BR - Brasile 139
VN - Vietnam 120
IT - Italia 71
HK - Hong Kong 38
IN - India 25
FI - Finlandia 24
GB - Regno Unito 24
IE - Irlanda 24
DE - Germania 21
CA - Canada 20
FR - Francia 19
NL - Olanda 17
MY - Malesia 14
ES - Italia 11
CO - Colombia 9
EC - Ecuador 9
PL - Polonia 8
AR - Argentina 7
IQ - Iraq 7
PE - Perù 7
ZA - Sudafrica 7
EG - Egitto 6
JP - Giappone 6
KR - Corea 6
MX - Messico 6
SA - Arabia Saudita 6
AT - Austria 5
BD - Bangladesh 5
ID - Indonesia 5
TR - Turchia 5
VE - Venezuela 5
BH - Bahrain 4
CL - Cile 4
PH - Filippine 4
RU - Federazione Russa 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
GR - Grecia 3
IR - Iran 3
MA - Marocco 3
PK - Pakistan 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
BG - Bulgaria 2
GT - Guatemala 2
IL - Israele 2
JO - Giordania 2
SK - Slovacchia (Repubblica Slovacca) 2
UA - Ucraina 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.428
Città #
Dallas 426
Singapore 169
Ashburn 125
San Jose 87
The Dalles 67
Ho Chi Minh City 45
Beijing 44
Shanghai 41
Hong Kong 34
Santa Clara 34
Los Angeles 33
Boardman 31
New York 24
Dublin 23
Helsinki 22
Milan 21
Hanoi 19
São Paulo 14
Chennai 13
Buffalo 10
Amsterdam 9
Kuala Lumpur 9
Haiphong 8
London 8
Rio de Janeiro 8
Council Bluffs 7
Cuenca 7
Atlanta 6
Cairo 6
Da Nang 6
Genoa 6
Montreal 6
Phoenix 6
Orem 5
Seattle 5
São Luís 5
Belfast 4
Boston 4
Brooklyn 4
Bắc Ninh 4
Jeddah 4
Naples 4
Queens 4
Toronto 4
Warsaw 4
Ankara 3
Bologna 3
Can Tho 3
Chapel Hill 3
Chicago 3
Denver 3
Frankfurt am Main 3
Grumo Nevano 3
Manama 3
Medellín 3
Mexico City 3
Paris 3
Ribeirão Preto 3
Santiago 3
Tashkent 3
Amman 2
Arequipa 2
Athens 2
Baghdad 2
Barcelona 2
Bekasi 2
Belo Horizonte 2
Bogotá 2
Boydton 2
Brasília 2
Bristol 2
Buk-gu 2
Buon Ma Thuot 2
Charlemont 2
Charlotte 2
Curitiba 2
Des Moines 2
Dongdaemun-gu 2
Dubai 2
Durban 2
Emden 2
Foz do Iguaçu 2
Glasgow 2
Go Vap 2
Greensboro 2
Guadalajara 2
Guiyang 2
Hangzhou 2
Itajaí 2
Johannesburg 2
Kuala Selangor 2
Madrid 2
Mumbai 2
Nagareyama 2
New Delhi 2
Nuremberg 2
Pelotas 2
Pittsburgh 2
Porto Alegre 2
Quezon City 2
Totale 1.550
Nome #
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 433
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 111
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 107
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 91
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS‐CoV‐2 infection 82
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 70
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 66
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 63
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 61
Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance 56
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 55
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 54
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 53
Dialysis-associated infection prevention and surveillance trial: an easy, feasible and effective bundle for infection prevention 52
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 51
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 49
ESCMID COVID-19 living guidelines: drug treatment and clinical management 48
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization 48
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 47
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 47
Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders 44
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 43
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 42
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 42
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 41
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 40
Role of liposomal amphotericin B in intensive care unit: an expert opinion paper 39
Elevating fungal care: bridging Brazil’s healthcare practices to global standards 38
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions 38
What do clinicians mean by epidemics' preparedness 37
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 36
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 36
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 35
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply 35
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere! 32
Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study 23
European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease 23
Successful treatment and secondary prophylaxis with pritelivir for a recurrent multidrug-resistant herpes simplex virus 1 infection in an allogeneic haematopoietic stem cell transplant recipient 22
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV‐1 infection 22
Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment 22
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort 22
Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort study 22
Corrigendum to: “Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)” Clinical Microbiology and Infection 26 (2020) 1545–1553 21
Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients 20
Reliable timescale inference of HBV genotype A origin and phylodynamics 19
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 17
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study) 11
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia: external validation with decision curve analysis 6
Primary Therapy for Invasive Aspergillosis With Triazoles or L-AmB: A Multicenter Retrospective Study 5
Use of Aztreonam-avibactam for infections caused by MBL-producing Enterobacterales 5
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia—Author's reply 1
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study 1
Reply to Comment on “Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of Candida bloodstream infections: A retrospective multicenter cohort study” 1
Monotherapy vs. combination therapy for Enterococcus faecalis bacteraemia: a target trial emulation 1
Totale 2.486
Categoria #
all - tutte 11.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202323 0 0 0 0 0 0 0 0 0 0 20 3
2023/2024240 13 11 43 8 13 41 12 18 7 17 28 29
2024/2025397 11 0 3 11 14 47 31 21 81 104 31 43
2025/20261.826 126 143 370 115 140 108 317 104 100 120 106 77
Totale 2.486